Results 121 to 130 of about 20,173 (237)

Comparative Efficacy and Safety of Netarsudil-Containing Interventions for Intraocular Pressure Control: A Systematic Review and Network Meta-Analysis. [PDF]

Cureus
Awan B, Elsaigh M, Tariq A, Badee M.
europepmc   +1 more source

Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open‐angle glaucoma patients already receiving 0.5% timolol [PDF]

, 2006
Ciro Costagliola, Claudio Campa, Francesco Parmeggiani, Carlo Incorvaia, Paolo Perri, Sergio D’Angelo, Giuseppe Lamberti, Adolfo Sebastiani   +7 more
openalex   +1 more source

Syncope and falls due to timolol eye drops [PDF]

, 2006
Marije E Müller, Nathalie van der Velde, Jaap W M Krulder, Tischa J. M. van der Cammen   +3 more
openalex   +1 more source

Efficacy and Safety of a Fixed-Dose Combination of Brinzolamide 1%/Timolol 0.5% vs. Dorzolamide 2%/Timolol 0.5% in Indian Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: A Randomized Phase 3 Study. [PDF]

Cureus
Bhagat P, Singhania M, Navare S, Mazumdar M, Paul C, Shet S, Vks K, Nicholsan A, Bansal N, Jain P.   +9 more
europepmc   +1 more source

Characteristic Effects of .ALPHA.1-.BETA.1,2-Adrenergic Blocking Agent, Carvedilol, on [Ca2+]i in Ventricular Myocytes Compared With Those of Timolol and Atenolol.

, 2002
Atsushi Yao, Osami Kohmoto, Tomomi Oyama, Yasuyuki Sugishita, Tatsuya Shimizu, Kazumasa Harada, Hiroshi Matsui, Issei Komuro, Ryozo Nagai, Hiroshi Matsuo, Takashi Serizawa, Takashi Maruyama, Toshiyuki Takahashi   +12 more
openalex   +2 more sources

Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components [PDF]

, 2007
A. G. P. Konstas, Ioannis Katsimpris, K. Kaltsos, I. Georgiadou, A Kordelou, Lindsay A. Nelson, William C. Stewart   +6 more
openalex   +1 more source

Randomized Clinical Trial of Intraocular Pressure-Lowering Medications on Preventing Spikes in Intraocular Pressure Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections. [PDF]

Ophthalmol Ther
Soomsawasdi P, Rojananuangnit K, Arayangkoon E, Chantiwas R, Pengrungreungwong S, Preawsampran N, Tinpowong N, Samakhararaksakul R, Katkingkaew K, Seekhum N, Sathim W.   +10 more
europepmc   +1 more source

Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model [PDF]

, 2007
William C. Stewart, Jeanette A. Stewart, MA Mychaskiw   +2 more
openalex   +1 more source

Evidence in Practice: A Review of Real-Life Studies and Clinical Experience with the Preservative-Free Tafluprost (0.0015%) and Timolol (0.5%) Fixed-Dose Combination. [PDF]

Clin Ophthalmol
Hollo G.
europepmc   +1 more source

Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medication. [PDF]

Med Gas Res
Soltani G, Shalaby WS, Razeghinejad R.
europepmc   +1 more source